B-CELL NEOPLASM
Clinical trials for B-CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new B-CELL NEOPLASM trials appear
Sign up with your email to follow new studies for B-CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: drug combo targets HIV-Linked cancers
Disease control Recruiting nowThis early-stage trial tests whether adding the drug pomalidomide to standard chemotherapy (with or without rituximab) is safe and effective for people with HIV who have aggressive B-cell non-Hodgkin lymphoma. About 25 adults with high-risk features will receive up to 6 cycles of…
Matched conditions: B-CELL NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New hope for kids with relapsed blood cancer: experimental cell therapy shows promise
Disease control Recruiting nowThis study tests a new treatment called MB-CART2019.1 in children and teens (ages 6 months to under 18) with B-cell cancers that came back or didn't respond to previous treatments. The therapy uses the patient's own immune cells, modified to attack cancer cells. The main goals ar…
Matched conditions: B-CELL NEOPLASM
Phase: PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC